Press Releases Sprint Bioscience AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 11:29:54 2024-05-15 EDT			5-day change	1st Jan Change
1.334 ^SEK	+9.88%		-1.91%	-23.11%

05-08	Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-14	Sprint Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Sprint Bioscience - Improved sales and activity	05-10	AQ
Positive preclinical results in Sprint Bioscience's oncology program targeting TREX1	04-11	AQ
New data from the VPS34 program published	03-20	AQ
Sprint Bioscience participates in a delegation trip to Washington DC	03-08	AQ
Sprint Bioscience Q4 2023 - A major step towards break-even	02-15	AQ
Sprint Bioscience’s DISA program further validated in two recent scientific publications	01-22	AQ
Sprint Bioscience - Replacing Decipher as a VPS34 partner	01-02	AQ
Sprint Bioscience - Easing pressure and a sharper focus on value drivers	11-20	AQ
Sprint Bioscience - New beginnings	23-09-13	AQ
Sprint Bioscience licenses the VADA (VRK1) program to Day One Biopharmaceuticals	23-08-16	AQ
Sprint Bioscience Q1 2023 - VADA deal needed	23-05-11	AQ
Sprint Bioscience presents preclinical data from the DISA program at research conference	23-05-02	AQ
Sprint Bioscience Q4 2022 - Temporary setbacks	23-02-16	AQ
Sprint Bioscience reports novel AML target proteins in ongoing collaboration	22-11-08	AQ
BioStock: Sprint Bioscience focuses on developing internal programs and partnering	22-10-27	AQ
Sprint Bioscience Q3 2022 - Seal the deal	22-10-26	AQ
BioStock: Sprint Bioscience increases innovation power	22-05-17	AQ
Sprint Bioscience expands collaboration to identify new target proteins	22-05-13	AQ
BioStock: Sprint Bioscience maintains focus on developing the portfolio	22-05-12	AQ
Sprint Bioscience appoints Scientific Advisory Board	22-05-11	AQ

No results for this search